Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

Impact of Prior History of Hospitalization for Heart Failure on Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Ogechukwu Samuel Obi

June 26, 2025

Presentation NY Valves 2025

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Presenter: Yukari Kobayashi

June 26, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Presenter: Philipp von Stein

June 26, 2025

Presentation NY Valves 2025

Clinical Impact of Cardiac Damage Across the Spectrum of Severity in Aortic Stenosis Patients

Presenter: Augustin Coisne

June 26, 2025

Presentation NY Valves 2024

Updates on Randomized Trials in Moderate AS

Presenter: Sammy Elmariah

June 06, 2024

Presentation NY Valves 2024

The Clinical Impact of Moderate AS

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Asymptomatic Severe AS – A Clinician’s Perspective

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

The Cardiac Damage Paradigm to Finetune theTiming of Aortic Valve Replacement

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

Prognostic Value of End-Organ Damage in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair

Presenter: Thomas Stocker

June 05, 2024

Advertisement

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Impact of Prior History of Hospitalization for Heart Failure on Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Impact of Cardiac Damage Staging in Patients With Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Insights From the TAVR UNLOAD Trial

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Clinical Impact of Cardiac Damage Across the Spectrum of Severity in Aortic Stenosis Patients

Updates on Randomized Trials in Moderate AS

The Clinical Impact of Moderate AS

Asymptomatic Severe AS – A Clinician’s Perspective

The Cardiac Damage Paradigm to Finetune theTiming of Aortic Valve Replacement

Prognostic Value of End-Organ Damage in Patients Undergoing Transcatheter Tricuspid Valve Edge-to-Edge Repair

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content